{"result": {"id": "chatcmpl-BBxs2pluq72AyV2KCgda8NAgCcLWQ", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>D.S. ASHRAF<|>PERSON<|>D.S. Ashraf is a researcher who contributed to the study on canonical senescence biomarkers and cell-cycle withdrawal published in Nature Communications.)\n##\n(\"entity\"<|>B. FERNANDEZ<|>PERSON<|>B. Fernandez is a researcher involved in the study of canonical senescence biomarkers and their integration with cell-cycle withdrawal.)\n##\n(\"entity\"<|>S.L. SPENCER<|>PERSON<|>S.L. Spencer is a researcher who co-authored the article on canonical senescence biomarkers in Nature Communications.)\n##\n(\"entity\"<|>J.P. DE MAGALHAES<|>PERSON<|>J.P. de Magalhaes is a researcher who authored the article discussing cellular senescence in normal physiology published in Science.)\n##\n(\"entity\"<|>D.S. LEEMAN<|>PERSON<|>D.S. Leeman is a researcher who contributed to the study on lysosome activation and quiescent neural stem cell activation during aging.)\n##\n(\"entity\"<|>K. HEBESTREIT<|>PERSON<|>K. Hebestreit is a researcher involved in the study of lysosome activation and its effects on quiescent neural stem cells.)\n##\n(\"entity\"<|>T. RUETZ<|>PERSON<|>T. Ruetz is a researcher who co-authored the article on lysosome activation and quiescent neural stem cell activation.)\n##\n(\"entity\"<|>A.E. WEBB<|>PERSON<|>A.E. Webb is a researcher who contributed to the study on lysosome activation and quiescent neural stem cells.)\n##\n(\"entity\"<|>A. MCKAY<|>PERSON<|>A. McKay is a researcher involved in the study of lysosome activation and quiescent neural stem cell activation.)\n##\n(\"entity\"<|>E.A. POLLINA<|>PERSON<|>E.A. Pollina is a researcher who co-authored the article on lysosome activation and quiescent neural stem cells.)\n##\n(\"entity\"<|>B.W. DULKEN<|>PERSON<|>B.W. Dulken is a researcher involved in the study of lysosome activation and its effects on quiescent neural stem cells.)\n##\n(\"entity\"<|>X. ZHAO<|>PERSON<|>X. Zhao is a researcher who contributed to the study on lysosome activation and quiescent neural stem cells.)\n##\n(\"entity\"<|>R.W. YEO<|>PERSON<|>R.W. Yeo is a researcher involved in the study of lysosome activation and quiescent neural stem cells.)\n##\n(\"entity\"<|>T.T. HO<|>PERSON<|>T.T. Ho is a researcher who co-authored the article on lysosome activation and quiescent neural stem cells.)\n##\n(\"entity\"<|>J.R. NEVINS<|>PERSON<|>J.R. Nevins is a researcher who has contributed to the understanding of the Rb/E2F pathway and its implications in cancer.)\n##\n(\"entity\"<|>N. DYSON<|>PERSON<|>N. Dyson is a researcher who studied the regulation of E2F by pRB-family proteins.)\n##\n(\"entity\"<|>R.C. SEARS<|>PERSON<|>R.C. Sears is a researcher who has explored signaling networks linking cell proliferation and cell fate.)\n##\n(\"entity\"<|>J.M. TRIMARCHI<|>PERSON<|>J.M. Trimarchi is a researcher who has studied the E2F family and its regulatory mechanisms.)\n##\n(\"entity\"<|>S. POLAGER<|>PERSON<|>S. Polager is a researcher who has investigated the role of E2F in cell fate decisions.)\n##\n(\"entity\"<|>G. YAO<|>PERSON<|>G. Yao is a researcher who has studied the bistable Rb-E2F switch and its role in cell cycle entry.)\n##\n(\"entity\"<|>X. WANG<|>PERSON<|>X. Wang is a researcher who has contributed to the understanding of quiescence and cell growth memory.)\n##\n(\"entity\"<|>S.D. CAPPELL<|>PERSON<|>S.D. Cappell is a researcher who has studied the irreversible inactivation of APC(Cdh1) in cell-cycle entry.)\n##\n(\"entity\"<|>D. BEAUSÉJOUR<|>PERSON<|>D. Beauséjour is a researcher who has explored the reversal of human cellular senescence and the roles of p53 and p16 pathways.)\n##\n(\"entity\"<|>J.W. SHAY<|>PERSON<|>J.W. Shay is a researcher who has studied the roles of RB and p53 in regulating human cellular senescence.)\n##\n(\"relationship\"<|>D.S. ASHRAF<|>NATURAL COMMUNICATION<|>D.S. Ashraf is a co-author of the research article discussing canonical senescence biomarkers in Nature Communications.<|>7)\n##\n(\"relationship\"<|>B. FERNANDEZ<|>NATURAL COMMUNICATION<|>B. Fernandez is a co-author of the research article discussing canonical senescence biomarkers in Nature Communications.<|>7)\n##\n(\"relationship\"<|>S.L. SPENCER<|>NATURAL COMMUNICATION<|>S.L. Spencer is a co-author of the research article discussing canonical senescence biomarkers in Nature Communications.<|>7)\n##\n(\"relationship\"<|>J.P. DE MAGALHAES<|>SCIENCE<|>J.P. de Magalhaes is the author of the article discussing cellular senescence in normal physiology published in Science.<|>7)\n##\n(\"relationship\"<|>D.S. LEEMAN<|>LYSOSOME ACTIVATION<|>D.S. Leeman is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>K. HEBESTREIT<|>LYSOSOME ACTIVATION<|>K. Hebestreit is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>T. RUETZ<|>LYSOSOME ACTIVATION<|>T. Ruetz is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>A.E. WEBB<|>LYSOSOME ACTIVATION<|>A.E. Webb is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>A. MCKAY<|>LYSOSOME ACTIVATION<|>A. McKay is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>E.A. POLLINA<|>LYSOSOME ACTIVATION<|>E.A. Pollina is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>B.W. DULKEN<|>LYSOSOME ACTIVATION<|>B.W. Dulken is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>X. ZHAO<|>LYSOSOME ACTIVATION<|>X. Zhao is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>R.W. YEO<|>LYSOSOME ACTIVATION<|>R.W. Yeo is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>T.T. HO<|>LYSOSOME ACTIVATION<|>T.T. Ho is a co-author of the study on lysosome activation and quiescent neural stem cell activation during aging.<|>7)\n##\n(\"relationship\"<|>J.R. NEVINS<|>RB/E2F PATHWAY<|>J.R. Nevins has contributed to the understanding of the Rb/E2F pathway, linking him to the biological process.<|>8)\n##\n(\"relationship\"<|>N. DYSON<|>RB/E2F PATHWAY<|>N. Dyson has studied the regulation of E2F by pRB-family proteins, establishing a connection to the Rb/E2F pathway.<|>8)\n##\n(\"relationship\"<|>R.C. SEARS<|>RB/E2F PATHWAY<|>R.C. Sears has explored signaling networks linking cell proliferation and the Rb/E2F pathway, connecting him to the biological process.<|>8)\n##\n(\"relationship\"<|>J.M. TRIMARCHI<|>RB/E2F PATHWAY<|>J.M. Trimarchi has studied the E2F family, linking him to the Rb/E2F pathway and its regulatory mechanisms.<|>8)\n##\n(\"relationship\"<|>S. POLAGER<|>RB/E2F PATHWAY<|>S. Polager has investigated the role of E2F in cell fate decisions, establishing a relationship with the Rb/E2F pathway.<|>8)\n##\n(\"relationship\"<|>G. YAO<|>RB/E2F PATHWAY<|>G. Yao has studied the bistable Rb-E2F switch, linking him to the Rb/E2F pathway and its role in cell cycle entry.<|>8)\n##\n(\"relationship\"<|>X. WANG<|>QUIESCENT NEURAL STEM CELLS<|>X. Wang has contributed to the understanding of quiescence and its relationship with muscle stem cells, linking him to the cell type.<|>7)\n##\n(\"relationship\"<|>S.D. CAPPELL<|>APC/C<|>S.D. Cappell has studied the inactivation of APC(Cdh1), establishing a connection to the factor involved in cell cycle regulation.<|>8)\n##\n(\"relationship\"<|>D. BEAUSÉJOUR<|>HUMAN CELLULAR SENESCENCE<|>D. Beauséjour has explored the reversal of human cellular senescence, linking him to the biological process.<|>8)\n##\n(\"relationship\"<|>J.W. SHAY<|>HUMAN CELLULAR SENESCENCE<|>J.W. Shay has studied the roles of RB and p53 in regulating human cellular senescence, establishing a connection to the biological process.<|>8)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": [], "audio": null, "function_call": null, "tool_calls": null}}], "created": 1742191450, "model": "gpt-4o-mini-2024-07-18", "object": "chat.completion", "service_tier": "default", "system_fingerprint": "fp_3267753c5d", "usage": {"completion_tokens": 2320, "prompt_tokens": 5174, "total_tokens": 7494, "completion_tokens_details": {"accepted_prediction_tokens": 0, "audio_tokens": 0, "reasoning_tokens": 0, "rejected_prediction_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 4224}}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n\n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [research article, person, cell type, biological process, gene, institution, factor]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n\n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: an integer score between 1 to 10, indicating strength of the relationship between the source entity and target entity\nFormat each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n\n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n\n4. If you have to translate into English, just translate the descriptions, nothing else!\n\n5. When finished, output <|COMPLETE|>.\n\n-Examples-\n######################\n\nExample 1:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\n Become Activated upon Brain Injury.Cell Stem Cell2015,17, 329–340. [CrossRef]\n44.Rodgers, J.T.; Schroeder, M.D.; Ma, C.; Rando, T.A. HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of\nStem Cells into GAlert.Cell Rep.2017,19, 479–486. [CrossRef]\n45.Lee, G.; Espirito Santo, A.I.; Zwingenberger, S.; Cai, L.; Vogl, T.; Feldmann, M.; Horwood, N.J.; Chan, J.K.; Nanchahal, J. Fully\nreduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert.Proc. Natl. Acad. Sci. USA\n2018,115, E4463–E4472.\n46. Baker, D.J.; Sedivy, J.M. Probing the depths of cellular senescence. J. Cell Biol.2013,202, 11–13. [CrossRef]\n47. Van Deursen, J.M. The role of senescent cells in ageing. Nature2014,509,\n------------------------\noutput:\n(\"entity\"<|>CELL STEM CELL<|>RESEARCH ARTICLE<|>A research article published in Cell Stem Cell in 2015 discussing activation upon brain injury)\n##\n(\"entity\"<|>HGFA<|>FACTOR<|>HGFA is an injury-regulated systemic factor that induces the transition of stem cells into GAlert)\n##\n(\"entity\"<|>GAlert<|>CELL TYPE<|>GAlert is a state of stem cells that is induced by HGFA during injury)\n##\n(\"entity\"<|>CELL REPORT<|>RESEARCH ARTICLE<|>A research article published in Cell Reports in 2017 discussing the role of HGFA in stem cell transition)\n##\n(\"entity\"<|>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA<|>RESEARCH ARTICLE<|>A research article published in PNAS in 2018 discussing the effects of fully reduced HMGB1 on tissue regeneration)\n##\n(\"entity\"<|>HMGB1<|>FACTOR<|>HMGB1 is a factor that accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert)\n##\n(\"entity\"<|>JOURNAL OF CELL BIOLOGY<|>RESEARCH ARTICLE<|>A research article published in the Journal of Cell Biology in 2013 discussing cellular senescence)\n##\n(\"entity\"<|>NATURE<|>RESEARCH ARTICLE<|>A research article published in Nature in 2014 discussing the role of senescent cells in aging)\n##\n(\"entity\"<|>D.J. BAKER<|>PERSON<|>D.J. Baker is a researcher who has probed the depths of cellular senescence)\n##\n(\"entity\"<|>J.M. SEDIVY<|>PERSON<|>J.M. Sedivy is a researcher who has probed the depths of cellular senescence)\n##\n(\"entity\"<|>J.M. VAN DEURSEN<|>PERSON<|>J.M. Van Deursen is a researcher discussing the role of senescent cells in aging)\n##\n(\"relationship\"<|>HGFA<|>GAlert<|>HGFA induces the transition of stem cells into GAlert<|>8)\n##\n(\"relationship\"<|>HMGB1<|>GAlert<|>Fully reduced HMGB1 accelerates the regeneration of tissues by transitioning stem cells to GAlert<|>8)\n##\n(\"relationship\"<|>D.J. BAKER<|>JOURNAL OF CELL BIOLOGY<|>D.J. Baker authored a research article discussing cellular senescence in the Journal of Cell Biology<|>7)\n##\n(\"relationship\"<|>J.M. SEDIVY<|>JOURNAL OF CELL BIOLOGY<|>J.M. Sedivy authored a research article discussing cellular senescence in the Journal of Cell Biology<|>7)\n##\n(\"relationship\"<|>J.M. VAN DEURSEN<|>NATURE<|>J.M. Van Deursen authored a research article discussing the role of senescent cells in aging in Nature<|>7)\n<|COMPLETE|>\n#############################\n\n\nExample 2:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\nshort exposure (6 h) to either drug was sufficient to inhibit ly-\n\nsosomal function in REF cells, evident by the impaired pro-\n\nteolytic degradation within the lysosomal compartment (\n\nSI\n\nAppendix\n\n, Fig. S5\nA\n). When quiescent cells were treated with\n\neither of these 2 lysosomal inhibitors, increasingly higher serum\nconcentrations were required to activate cells to reenter the cell\n\ncycle, in a drug dose-dependent manner (Fig. 4\n\nB\n–\nD\n; red arrow\n\npoints to serum concentration for activating\n\n∼\n50% of cells, judged\n\nbased on EdU incorporation, E2f-GFP reporter, and propidium\n\niodide [PI] staining, respectively). Correspondingly, at a given\nserum concentration (e.g., 4% serum), a decreasing percentage of\n\ncells were able to reenter the cell cycle (EdU\n+\n)withanincreasing\n\ndose of either lysosomal inhibitor, Baf or CQ (Fig. 4\n\nB\n). The ly-\n\nsosomal inhibition-caused quiescence deepening occurred re-\n\ngardless of the preceding quiescence depth before drug treatment:\n\nAs shown in\n\n\n------------------------\noutput:\n(\"entity\"<|>REF CELLS<|>CELL TYPE<|>REF cells are a type of cell used in research that exhibit lysosomal function and are affected by drug treatments.)\n##\n(\"entity\"<|>LYSOSOMAL INHIBITORS<|>FACTOR<|>Lysosomal inhibitors are substances that impair lysosomal function, affecting cellular processes such as proteolytic degradation.)\n##\n(\"entity\"<|>BAF<|>FACTOR<|>Baf is a specific lysosomal inhibitor that affects the reentry of quiescent cells into the cell cycle.)\n##\n(\"entity\"<|>CQ<|>FACTOR<|>CQ is another lysosomal inhibitor that impacts the ability of quiescent cells to reactivate and reenter the cell cycle.)\n##\n(\"entity\"<|>EDU INCORPORATION<|>BIOLOGICAL PROCESS<|>EdU incorporation is a method used to measure cell proliferation by detecting newly synthesized DNA in cells.)\n##\n(\"entity\"<|>E2F-GFP REPORTER<|>BIOLOGICAL PROCESS<|>E2F-GFP reporter is a tool used to monitor cell cycle progression and activation in response to serum concentrations.)\n##\n(\"entity\"<|>PROPIDIUM IODIDE STAINING<|>BIOLOGICAL PROCESS<|>Propidium iodide staining is a technique used to assess cell viability and cell cycle status by staining DNA.)\n##\n(\"relationship\"<|>REF CELLS<|>LYSOSOMAL INHIBITORS<|>Lysosomal inhibitors impair the lysosomal function in REF cells, affecting their ability to degrade proteins and reenter the cell cycle.<|>8)\n##\n(\"relationship\"<|>REF CELLS<|>BAF<|>Baf treatment leads to a dose-dependent inhibition of REF cells' ability to reenter the cell cycle.<|>7)\n##\n(\"relationship\"<|>REF CELLS<|>CQ<|>CQ treatment also inhibits REF cells' ability to reactivate and reenter the cell cycle in a dose-dependent manner.<|>7)\n##\n(\"relationship\"<|>REF CELLS<|>EDU INCORPORATION<|>EdU incorporation is used to assess the percentage of REF cells that can reenter the cell cycle after treatment with lysosomal inhibitors.<|>6)\n##\n(\"relationship\"<|>REF CELLS<|>E2F-GFP REPORTER<|>The E2F-GFP reporter is utilized to monitor the activation of REF cells in response to serum concentrations.<|>6)\n##\n(\"relationship\"<|>REF CELLS<|>PROPIDIUM IODIDE STAINING<|>Propidium iodide staining is employed to evaluate the cell cycle status of REF cells after treatment with lysosomal inhibitors.<|>6)\n<|COMPLETE|>\n#############################\n\n\nExample 3:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\n lysosomal function continuously modulates quiescence\ndepth, acting like a dimmer switch (Fig. 6\n\nH\n).\n\nQuiescence Deepening Is Linked to Cellular Senescence and Aging.\n\nFinally, we examined whether and how deep quiescence in REF\n\ncells is related to the quiescent states of other cell types (case Q)\nand other nongrowth cellular states, such as senescence (case S).\n\nTo this end, we first developed a gene-expression signature in-\n\ndicating the quiescence depth in REF cells by performing a\nlinear regression analysis of the time-course RNA-seq data (see\n\nMaterials and Methods\n\nfor details). To identify a signature that\n\ncorresponds to a deepening of quiescence as opposed to simply\n\nhalting the cell cycle, we omitted the proliferating sample (0 d) from\nthe analysis and used samples corresponding to 2- to 16-d\nserum\n\nstarvation (i.e., shallow to deep quiescence) to build the regression\n\nmodel. We next applied this quiescence-depth signature to other\npublicly available RNA-seq datase\nts related to cases Q and S, above.\n\nAB CD\n\nE\n\nGH\n\nF\n\n\n\n------------------------\noutput:\n(\"entity\"<|>LYSOSOMAL FUNCTION<|>BIOLOGICAL PROCESS<|>Lysosomal function is involved in modulating cellular quiescence and is linked to cellular senescence and aging.)\n##\n(\"entity\"<|>QUIESCENCE<|>BIOLOGICAL PROCESS<|>Quiescence refers to a state of cellular dormancy where cells are not actively dividing but can be activated under certain conditions.)\n##\n(\"entity\"<|>CELLULAR SENESCENCE<|>BIOLOGICAL PROCESS<|>Cellular senescence is a state where cells cease to divide and can contribute to aging and tissue dysfunction.)\n##\n(\"entity\"<|>AGING<|>BIOLOGICAL PROCESS<|>Aging is the process of becoming older, characterized by a gradual decline in physiological function and increased susceptibility to diseases.)\n##\n(\"entity\"<|>REF CELLS<|>CELL TYPE<|>REF cells are a type of cell used in research to study quiescence and cellular responses to various stimuli.)\n##\n(\"entity\"<|>GENE-EXPRESSION SIGNATURE<|>GENE<|>A gene-expression signature is a specific pattern of gene expression that can indicate particular cellular states, such as quiescence depth.)\n##\n(\"relationship\"<|>LYSOSOMAL FUNCTION<|>QUIESCENCE<|>Lysosomal function modulates quiescence, affecting how cells enter and maintain this dormant state<|>8)\n##\n(\"relationship\"<|>QUIESCENCE<|>CELLULAR SENESCENCE<|>Quiescence is linked to cellular senescence, as both processes involve changes in cell cycle activity and can influence aging<|>7)\n##\n(\"relationship\"<|>CELLULAR SENESCENCE<|>AGING<|>Cellular senescence contributes to the aging process by promoting tissue dysfunction and limiting regenerative capacity<|>9)\n##\n(\"relationship\"<|>REF CELLS<|>QUIESCENCE<|>REF cells are used to study the mechanisms of quiescence and how it can be influenced by various factors<|>6)\n##\n(\"relationship\"<|>GENE-EXPRESSION SIGNATURE<|>QUIESCENCE<|>The gene-expression signature developed indicates the depth of quiescence in REF cells, providing insights into their cellular state<|>8)\n<|COMPLETE|>\n#############################\n\n\n\n-Real Data-\n######################\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext: .Ashraf, H.M.; Fernandez, B.; Spencer, S.L. The intensities of canonical senescence biomarkers integrate the duration of cell-cycle\nwithdrawal.Nat. Commun.2023,14, 4527. [CrossRef] [PubMed]\n57. de Magalhaes, J.P. Cellular senescence in normal physiology. Science2024,384, 1300–1301. [CrossRef] [PubMed]\n58.Leeman, D.S.; Hebestreit, K.; Ruetz, T.; Webb, A.E.; McKay, A.; Pollina, E.A.; Dulken, B.W.; Zhao, X.; Yeo, R.W.;Ho, T.T.; et al.\nLysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging.Science2018,359,\n1277–1283. [CrossRef] [PubMed]\n59. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev.1998,12, 2245–2262. [CrossRef]\n60. Nevins, J.R. The Rb/E2F pathway and cancer. Hum. Mol. Genet.2001,10, 699–703. [CrossRef]\n61.Sears, R.C.; Nevins, J.R. Signaling networks that link cell proliferation and cell fate.J. Biol. Chem.2002,277, 11617–11620.\n[CrossRef]\n62. Trimarchi, J.M.; Lees, J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol.2002,3, 11–20. [CrossRef] [PubMed]\n63. Polager, S.; Ginsberg, D. E2F-at the crossroads of life and death. Trends Cell Biol.2008,18, 528–535. [CrossRef] [PubMed]\n64.Yao, G.; Lee, T.J.; Mori, S.; Nevins, J.R.; You, L. A bistable Rb-E2F switch underlies the restriction point.Nat. Cell Biol.2008,10,\n476–482. [CrossRef] [PubMed]\n65.Yao, G.; Tan, C.; West, M.; Nevins, J.R.; You, L. Origin of bistability underlying mammalian cell cycle entry.Mol. Syst. Biol.2011,\n7, 485. [CrossRef] [PubMed]\n66.Wang, X.; Fujimaki, K.; Mitchell, G.C.; Kwon, J.S.; Della Croce, K.; Langsdorf, C.; Zhang, H.H.; Yao, G. Exit from quiescence\ndisplays a memory of cell growth and division. Nat. Commun.2017,8, 321. [CrossRef] [PubMed]\n67.Cappell, S.D.; Chung, M.; Jaimovich, A.; Spencer, S.L.; Meyer, T. Irreversible APC(Cdh1) Inactivation Underlies the Point of No\nReturn for Cell-Cycle Entry.Cell2016,166, 167–180. [CrossRef] [PubMed]\n68.Cappell, S.D.; Mark, K.G.; Garbett, D.; Pack, L.R.; Rape, M.; Meyer, T. EMI1 switches from being a substrate to an inhibitor of\nAPC/C(CDH1) to start the cell cycle. Nature2018,558, 313–317. [CrossRef] [PubMed]\n69.Benjamin, D.I.; Both, P.; Benjamin, J.S.; Nutter, C.W.; Tan, J.H.; Kang, J.; Machado, L.A.; Klein, J.D.; de Morree, A.; Kim, S.; et al.\nFasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling.Cell Metab.2022,34,\n902–918.e6. [CrossRef]\n70.Shay, J.W.; Pereira-Smith, O.M.; Wright, W.E. A role for both RB and p53 in the regulation of human cellular senescence.Exp. Cell\nRes.1991,196, 33–39. [CrossRef]\n71.Beauséjour, C.M.; Krtolica, A.; Galimi, F.; Narita, M.; Lowe, S.W.; Yaswen, P.; Campisi, J. Reversal of human cellular senescence:\nRoles of the p53 and p16 pathways. EMBO J.2003,22, 4212–4222. [CrossRef] [PubMed]\n72.Sage, J.; Miller, A.L.; Perez-Mancera, P.A.; Wysocki, J.M.; Jacks, T. Acute mutation of retinoblastoma gene function is sufﬁcient for\ncell cycle re-entry.Nature2003,424, 223–228. [CrossRef] [PubMed]\n73.Dirac, A.M.; Bernards, R. Reversal of senescence in mouse ﬁbroblasts through lentiviral suppression of p53.J. Biol. Chem.2003,\n278, 11731–11734. [CrossRef] [PubMed]\n74.Pajalunga, D.; Mazzola, A.; Salzano, A.M.; Biferi, M.G.; De Luca, G.; Crescenzi, M. Critical requirement for cell cycle inhibitors in\nsustaining nonproliferative states. J. Cell Biol.2007,176, 807–818. [CrossRef] [PubMed]\n75.Reyes, J\n######################\noutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>NATURAL COMMUNICATION<|>RESEARCH ARTICLE<|>A research article published in Nature Communications in 2023 discussing the intensities of canonical senescence biomarkers and their integration with cell-cycle withdrawal duration.)\n##\n(\"entity\"<|>SCIENCE<|>RESEARCH ARTICLE<|>A research article published in Science in 2024 discussing cellular senescence in normal physiology.)\n##\n(\"entity\"<|>LYSOSOME ACTIVATION<|>BIOLOGICAL PROCESS<|>Lysosome activation is a biological process that clears aggregates and enhances the activation of quiescent neural stem cells during aging.)\n##\n(\"entity\"<|>QUIESCENT NEURAL STEM CELLS<|>CELL TYPE<|>Quiescent neural stem cells are a type of stem cell that remain inactive until activated, playing a role in tissue regeneration.)\n##\n(\"entity\"<|>E2F<|>FACTOR<|>E2F is a family of transcription factors that regulate the cell cycle and are influenced by retinoblastoma (Rb) family proteins.)\n##\n(\"entity\"<|>RB/E2F PATHWAY<|>BIOLOGICAL PROCESS<|>The Rb/E2F pathway is a critical regulatory mechanism in the cell cycle that influences cell proliferation and differentiation.)\n##\n(\"entity\"<|>HUMAN CELLULAR SENESCENCE<|>BIOLOGICAL PROCESS<|>Human cellular senescence is a state where cells stop dividing and can contribute to aging and age-related diseases.)\n##\n(\"entity\"<|>CELL METABOLISM<|>BIOLOGICAL PROCESS<|>Cell metabolism refers to the biochemical processes that occur within cells, including energy production and nutrient utilization.)\n##\n(\"entity\"<|>APC/C<|>FACTOR<|>APC/C is an E3 ubiquitin ligase complex that regulates the cell cycle by targeting specific proteins for degradation.)\n##\n(\"entity\"<|>KETONE BODY SIGNALING<|>BIOLOGICAL PROCESS<|>Ketone body signaling is a metabolic pathway that influences cellular states, particularly in muscle stem cells during fasting.)\n##\n(\"entity\"<|>P53<|>FACTOR<|>P53 is a tumor suppressor protein that plays a crucial role in regulating the cell cycle and cellular senescence.)\n##\n(\"entity\"<|>P16<|>FACTOR<|>P16 is a cyclin-dependent kinase inhibitor that is involved in the regulation of the cell cycle and cellular senescence.)\n##\n(\"entity\"<|>MUSCLE STEM CELLS<|>CELL TYPE<|>Muscle stem cells are a type of stem cell that can differentiate into muscle cells and are involved in muscle regeneration.)\n##\n(\"relationship\"<|>NATURAL COMMUNICATION<|>LYSOSOME ACTIVATION<|>The research article discusses how lysosome activation enhances quiescent neural stem cell activation during aging, linking the two entities.<|>8)\n##\n(\"relationship\"<|>LYSOSOME ACTIVATION<|>QUIESCENT NEURAL STEM CELLS<|>Lysosome activation is crucial for clearing aggregates and enhancing the activation of quiescent neural stem cells.<|>8)\n##\n(\"relationship\"<|>SCIENCE<|>HUMAN CELLULAR SENESCENCE<|>The article discusses cellular senescence in normal physiology, establishing a connection between the two entities.<|>7)\n##\n(\"relationship\"<|>E2F<|>RB/E2F PATHWAY<|>E2F is regulated by the Rb/E2F pathway, which is essential for controlling cell cycle progression.<|>9)\n##\n(\"relationship\"<|>P53<|>HUMAN CELLULAR SENESCENCE<|>P53 plays a significant role in regulating human cellular senescence, linking the two entities.<|>8)\n##\n(\"relationship\"<|>P16<|>HUMAN CELLULAR SENESCENCE<|>P16 is involved in the regulation of cellular senescence, establishing a relationship with the process.<|>8)\n##\n(\"relationship\"<|>KETONE BODY SIGNALING<|>MUSCLE STEM CELLS<|>Ketone body signaling influences the state of muscle stem cells during fasting, linking the two entities.<|>7)\n##\n(\"relationship\"<|>APC/C<|>RB/E2F PATHWAY<|>APC/C is involved in the regulation of the RB/E2F pathway, affecting cell cycle dynamics.<|>7)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "gpt-4o-mini", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}